亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

透明質酸 CAS號: 9004-61-9

 
 
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 9004-61-9
過期 長期有效
更新 2020-06-18 10:08
 

隨州市紅旗化工有限公司

企業會員第15年
資料未認證
保證金未繳納
詳細說明

 透明質酸
CAS號: 9004-61-9
中文同義詞: 玻璃(糖醛)酸;透明質酸;動物糖醛酸;透明質酸名玻璃酸;玻璃酸;透明質酸,
英文名稱: Hyaluronic acid
英文同義詞: [BETA-SODIUM-GLUCONATE-(1,3)-BETA-N-ACETYL-D-GLUCOSAMINE-1,4-]N;COPOLY(BETA-GLUCURONIC ACID-[1->3]-BETA-N-ACETYLGLUCOSAMINE-[1->4] SODIUM SALT;HYALURONIC ACID NA-SALT;HYALURONIC ACID, SODIUM SALT, STREPTOCOCCUS SPECIES;HYALURONIC ACID SODIUM;HYALURONIC ACID HUMAN SODIUM SALT;POLY(BETA-GLUCURONIC ACID-[1->3]-BETA-N-ACETYLGLUCOSAMINE-[1->4]), ALTERNATING;SODIUM HYALURONATE (STREPTOCOCCUS)
分子式: C14H22NNaO11
分子量: 403.31
EINECS號: 232-678-0
標準:醫藥級
含量:≥95%
性狀:白色(類白色顆粒)粉末
用途:用途  眼科“黏性手術”必備藥物。應用于白內障手術,其鈉鹽易存留于前房,使前房維持一定深度,保持清晰的手術視野,減少手術后炎癥和并發癥的發生,從而提高手術矯正視力的效果。亦用于復雜視網膜脫離手術。
它還被作為理想的天然保濕因子,廣泛用于化妝品之中,能改善皮膚營養,使皮膚光華細嫩。
包裝:1kg/鋁箔袋

舉報收藏 0評論 0
更多>本企業其它產品
來氟米特 CAS號: 75706-12-6 頭孢曲松鈉 CAS;74578-69-1 福多斯坦 CAS號: 13189-98-5 克洛索隆 CAS;60200-06-8 磷酸吡哆醛 CAS號: 54-47-7 4-甲基噻唑-5-甲醛 CAS號: 82294-70-0 三氯苯噠唑 CAS:68786-66-3 5-乙酰水楊酸甲酯 CAS;16475-90-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |